MedTrace Logo

Study to Determine If the Volume Used to Dilute BOTOX Cosmetic™ for Injection Affects Its Overall Effect and Duration.

NCT00250952 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2005-11-09

No results posted yet for this study

Summary

It is thought that the amount of fluid used to dilute Botox for injection has an effect on the quality of the result and the duration of effect on the treatment of upper face rhytides, even though the dose remains the same.

The study was designed to test this thinking, using the crow's feet wrinkles as the treatment area.

Conditions

  • Skin Wrinkling

Interventions

DRUG

Botox Cosmetic™

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Carruthers Dermatology Centre

    lead OTHER

Principal Investigators

  • J. Alastair Carruthers, MD · Carruthers Dermatology Centre, Inc.

  • Jeffrey S Dover, MD · Skin Care Physicians of Chestnut Hill

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-02-28
Completion
2005-06-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00250952 on ClinicalTrials.gov